Nektar Therapeutics (NKTR) issued a statement confirming that it does not have any accounts at Silicon Valley Bank (SIVB), and it does not hold any cash deposits or securities at Silicon Valley Bank. At December 31, 2022, the company had approximately $505 million in cash and investments in marketable securities.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on NKTR: